abstract |
Described herein are compounds that are lysophosphatidine receptor antagonists. Also provided herein are pharmaceutical compositions and therapeutic agents comprising the compounds described herein for treating LPA-dependent or LPA-mediated diseases or disorders, as well as such antagonists alone or other compounds. A method of use in combination with is also described. |